Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GRINA | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | TCP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | CDC40 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | PCGF6 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | FBXO5 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | APAF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | H2AFZ | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | CYB5R4 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | DAZAP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | SERBP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |